BenzingaAUG 262 min read$BRBS

P/E Ratio Insights for Blue Ridge Bankshares - Blue Ridge Bankshares (AMEX:BRBS)

In the current market session, Blue Ridge Bankshares Inc. BRBS stock price is at $3.88, after a 3.60% decrease. However, over the past month, the company's stock went up by 6.15%, and in the past year, by 38.75%.

Original reporting

Benzinga · Benzinga Insights

Published Aug 26, 2025, 8:00 PM UTC

Analysis

alphai AI DeskAI-generated

Added to alphai Aug 26, 2025, 8:30 PM UTC. Informational, not investment advice.

How this was made

alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About alphai AI Desk Scoring methodology Report an issue

P/E Ratio Insights for Blue Ridge Bankshares - Blue Ridge Bankshares (AMEX:BRBS) — source image — Source · www.benzinga.com

Decision brief

The 30-second read

$BRBSNeutralLow

Why it matters

The P/E ratio insights could influence investor sentiment, but without broader industry comparison, the impact remains limited.

Market read

The news provides a snapshot of valuation metrics for BRBS, relevant for traders monitoring regional bank valuations but with limited immediate trading impact.

What to watch

Potential undervaluation due to temporary market sentiment or upcoming earnings reports; macroeconomic factors affecting regional banks could alter the outlook.

Timing: short-term (days to weeks)

Background

Blue Ridge Bankshares has shown consistent growth over the past year, with recent price declines possibly reflecting short-term market fluctuations.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$BRBSNeutralMedium confidence

Context

The article provides insights into Blue Ridge Bankshares' stock performance and valuation metrics, specifically its P/E ratio, which can influence trading decisions.

Expected impact

Potential slight upward movement if valuation is deemed attractive; however, current price stability suggests limited immediate impact.

Evidence & confidence

The analysis is based on recent price trends and P/E insights, but lacks detailed industry comparison and technical indicators.

Market effects

Sector

The banking sector may experience minor sentiment shifts based on valuation insights, but no significant sector-wide impact is anticipated.

Regional

Limited; the news pertains to a regional bank with no immediate macroeconomic implications.

Global

negligible; the information is specific to a regional bank and does not influence global markets.

Counterpoint

What could challenge this read

The current valuation may be justified given the company's recent growth and regional market conditions, suggesting caution against overreacting to P/E ratios alone.

Key entities

Company
Blue Ridge Bankshares
A regional bank listed on AMEX, with recent stock performance data.

Read at source ← All news

AUG 17

$BRBSMedAI 8/10

NC bank's latest deal fits its Atlanta-to-Richmond plan

HomeTrust Bancshares agreed to buy Blue Ridge Bankshares in an all-stock deal valued at about $448.1 million, expected to close in early Q1 2027. The transaction would nearly double HomeTrust’s branch network, lift assets to about $7 billion, and add about $1.9 billion each of loans and deposits. Blue Ridge exited regulatory issues tied to fintech partnerships.

americanbanker.com4 min

AUG 17

$BRBSMedAI 9/10

Blue Ridge Bankshares to Merge With HomeTrust in All-Stock Deal at 0.086 Exchange Ratio

Blue Ridge Bankshares (BRBS) signed a definitive all-stock merger with HomeTrust Bancshares (HTBI). Blue Ridge shareholders will receive 0.086 HomeTrust shares per Blue Ridge share, with cash for fractional shares. Boards approved unanimously; closing is expected in Q1 2027 pending approvals. The deal includes an $18.0 million termination fee and supporting voting and warrant-conversion agreements.

tradingview.com4 min

JUL 28

$BRBSMed

Blue Ridge Bankshares, Inc. Announces 2026 Second Quarter Results

Blue Ridge Bankshares (NYSE American: BRBS) reported a Q2 2026 net loss of $0.2 million, or $0.00 per diluted share, versus net income of $0.8 million in Q1 2026. The quarter included a $2.1 million after-tax credit-loss provision and $0.3 million after-tax severance. Loans grew at a 4% annualized rate; NIM was 2.91%.

prnewswire.com6 min

JUL 28

$BRBSMed

BLUE RIDGE BANKSHARES, INC. (BRBS): Results of Operations and Financial Condition

BLUE RIDGE BANKSHARES, INC. (BRBS) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 brbs-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Blue Ridge Bankshares, Inc. Announces 2026 Second Quarter Results Loan Growth Returns, Improved Deposit Mix, and Continued Reduction in Operating Expenses RICHMOND, VA, July 28, 2026 /PRNewswire/ -- Blue Ridge Bankshares, Inc

SEC EDGAR 8-K4 min

SEP 8

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

yahoo.com3 min